These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8502703)

  • 21. Hepatitis delta superinfection during alpha-interferon treatment for hepatitis B.
    Craxì A; Di Marco V; Bruno R; Fabiano C
    Ital J Gastroenterol; 1992 Jan; 24(1):19-20; discussion 20-1. PubMed ID: 1571575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of hepatitis delta virus (HDV) replication by lymphoblastoid human alpha interferon.
    Thomas HC; Farci P; Shein R; Karayiannis P; Smedile A; Caruso L; Gerin J
    Prog Clin Biol Res; 1987; 234():277-90. PubMed ID: 3628382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of IgM anti-HD during interferon therapy.
    Marinucci G; Hassan G; Di Giacomo C; Dato A; Barlattani A; Costa F
    Prog Clin Biol Res; 1993; 382():311-8. PubMed ID: 8502696
    [No Abstract]   [Full Text] [Related]  

  • 24. A randomized controlled trial of a 12-month course of recombinant human interferon-alpha in chronic delta (type D) hepatitis: a multicenter Italian study.
    Rosina F; Pintus C; Meschievitz C; Rizzetto M
    Hepatology; 1991 Jun; 13(6):1052-6. PubMed ID: 2050321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Interferon-alpha. A good treatment for some patients with chronic hepatitis B].
    Bruguera M; Sánchez Tapias JM
    Med Clin (Barc); 1991 Nov; 97(18):697-9. PubMed ID: 1770820
    [No Abstract]   [Full Text] [Related]  

  • 26. Replicative level of hepatitis C virus (HCV) in chronic hepatitis C.
    Hayashi N; Kamada T
    Intern Med; 1993 Dec; 32(12):944-5. PubMed ID: 8204979
    [No Abstract]   [Full Text] [Related]  

  • 27. [What are the indications for interferon therapy with regard to the significance of serologic and histologic findings and laboratory data?].
    Gerken G
    Internist (Berl); 1993 Nov; 34(11):1062-5. PubMed ID: 8282492
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of chronic hepatitis C with recombinant interferon alfa.
    Chen YK; Bala K
    West J Med; 1992 Jan; 156(1):72. PubMed ID: 1734608
    [No Abstract]   [Full Text] [Related]  

  • 29. Alpha interferon therapy in children with chronic active hepatitis B and delta virus infection.
    Kay MH; Wyllie R; Deimler C; Caulfield M; Steffen R; Baetz-Greenwalt B
    J Pediatr; 1993 Dec; 123(6):1001-4. PubMed ID: 8229507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hybridization using a digoxigenin-labeled probe for the detection of hepatitis delta virus].
    Sarría L; Gallego L; Lardelli P; Manzano D; Basaras M; Cisterna R
    Enferm Infecc Microbiol Clin; 1992 Oct; 10(8):470-3. PubMed ID: 1489775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum HCV RNA levels in patients with chronic hepatitis C given a second course of interferon alpha-2b treatment after relapse following initial treatment.
    Weiland O; Zhang YY; Widell A
    Scand J Infect Dis; 1993; 25(1):25-30. PubMed ID: 8384732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon therapy in hepatitis C--refractory hepatitis--report of the research subgroup of treatment of chronic hepatitis.
    Iino S
    Gastroenterol Jpn; 1993 Mar; 28 Suppl 4():139-42. PubMed ID: 8486225
    [No Abstract]   [Full Text] [Related]  

  • 33. Therapy of chronic delta hepatitis with interferon alfa-2b.
    Di Bisceglie AM; Martin P; Lisker-Melman M; Kassianides C; Korenman J; Bergasa NV; Baker B; Hoofnagle JH
    J Hepatol; 1990; 11 Suppl 1():S151-4. PubMed ID: 2079575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The interferon therapy of patients with chronic viral hepatitis: the factors affecting the treatment results].
    Kokoreva LN; Zmyzgova AV; Shalygina NB
    Ter Arkh; 1996; 68(2):10-4. PubMed ID: 8771646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of chronic delta hepatitis with alpha-2 recombinant interferon.
    Rizzetto M; Rosina F; Saracco G; Bellando PC; Actis GC; Bonino F; Smedile A; Trinchero P; Sansalvadore F; Pintus C
    J Hepatol; 1986; 3 Suppl 2():S229-33. PubMed ID: 3298410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical significance of the hepatitis Delta virus and its incidence in virus B positive chronic liver diseases].
    Horváth G; Tolvaj G; Dávid K
    Orv Hetil; 1992 Jul; 133 Suppl 1():39-44. PubMed ID: 1630804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Delta virus infection in hemodialyzed kidney patients and patients with chronic liver diseases].
    Ibrányi E; Mihály I; Kovács M; Telegdy L
    Orv Hetil; 1992 Jul; 133 Suppl 1():45-8. PubMed ID: 1321398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapy of chronic viral hepatitis with recombinant interferon-alpha].
    Ferenci P
    Acta Med Austriaca; 1992; 19(2):49-55. PubMed ID: 1509859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chronic hepatitis delta--the course and approaches to therapy].
    Blokhina NP; Ketiladze ES; Kelli EI; Viazov SO
    Klin Med (Mosk); 1991 Mar; 69(3):85-8. PubMed ID: 2067348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chronic hepatitis: the etiological spectrum. The implications for treatment].
    Velosa J; Ramalho F; Serejo F; Marinho R; de Moura MC
    Acta Med Port; 1993 Jun; 6(6):233-8. PubMed ID: 8368089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.